Today, Bulletproof™, the leader in clean coffee and functional nutrition products, introduces its next evolution: Coffee + ...

NOW is Ovarian Cancer Awareness Month – and the symptoms of this disease are so frequently misdiagnosed as “just bloating” or irritable bowel syndrome (IBS). Unlike some cancers, with obvious ...

"Beast Games" winner Jeff Allen hopes finding a cure for his son's rare disease will unlock new treatments for other brain ...

As a toddler, Lucas was diagnosed with Creatine Transporter Deficiency, or CTD, a rare genetic mutation that blocks the ...

Some dietary supplements can help improve endurance or power during training. Here are 5 supplements to consider adding to ...

In L.A., the hyper-optimized Erewhon Boyfriend tracks macros and cold plunges, but struggles with commitment and emotional depth.

Glimmer of hope emerges in pilot trial of people with mild cognitive impairment ...

Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator ...

Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the second half of ...

Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the ...

Jack Link's, the company that created the modern meat snack category, today announced the launch of its newest lineup: a full ...

Ropeginterferon alfa-2b-njft is currently FDA-approved and marketed as BESREMi (R) for the treatment of adults with polycythemia vera (PV). The Company is seeking a ropeginterferon alfa-2b-njft label ...